Use of the somatostatin analogue octreotide acetate in the treatment of encephalopathy associated with carcinoid tumor. Case report

Am J Clin Oncol. 1997 Dec;20(6):558-61. doi: 10.1097/00000421-199712000-00004.

Abstract

Carcinoid tumors may present in a variety of ways dependent on sites of disease and ectopic hormone secretion. This case report describes a patient having metastatic carcinoid tumor who developed encephalopathy of uncertain etiology. Treatment with the somatostatin analogue octreotide acetate resulted in dramatic improvement in his mental status. Several plausible mechanisms are discussed.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Brain Diseases / complications
  • Brain Diseases / drug therapy*
  • Carcinoid Tumor / complications
  • Carcinoid Tumor / drug therapy*
  • Humans
  • Liver Neoplasms / complications
  • Liver Neoplasms / drug therapy*
  • Male
  • Octreotide / therapeutic use*

Substances

  • Antineoplastic Agents, Hormonal
  • Octreotide